Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24
Closed -$974 789
2024
Q2
$974 Hold
24
﹤0.01% 892
2024
Q1
$971 Buy
+24
New +$902 ﹤0.01% 881
2023
Q4
Sell
-24
Closed -$676 756
2023
Q3
$676 Hold
24
﹤0.01% 878
2023
Q2
$1K Hold
24
﹤0.01% 869
2023
Q1
$1K Hold
24
﹤0.01% 889
2022
Q4
$1K Hold
24
﹤0.01% 864
2022
Q3
$1K Hold
24
﹤0.01% 902
2022
Q2
$1K Hold
24
﹤0.01% 905
2022
Q1
$1K Hold
24
﹤0.01% 916
2021
Q4
$1K Hold
24
﹤0.01% 928
2021
Q3
$1K Hold
24
﹤0.01% 928
2021
Q2
$1K Hold
24
﹤0.01% 932
2021
Q1
$1K Hold
24
﹤0.01% 932
2020
Q4
$1K Hold
24
﹤0.01% 893
2020
Q3
$1K Hold
24
﹤0.01% 890
2020
Q2
$1K Hold
24
﹤0.01% 948
2020
Q1
$1K Hold
24
﹤0.01% 924
2019
Q4
$1K Hold
24
﹤0.01% 875
2019
Q3
$1K Hold
24
﹤0.01% 882
2019
Q2
$1K Hold
24
﹤0.01% 976
2019
Q1
$1K Buy
+24
New +$881 ﹤0.01% 990

Other funds holding SNV

Front Row Advisors's SNV Position: Q3 2024 in Review

Front Row Advisors sold out of Synovus (SNV) in Q3 2024, closing a stake of 24 shares — an estimated $974 sold.

Front Row Advisors first reported a position in SNV in Q1 2019 and held it in 21 quarters. The position peaked at $1K in Q2 2023. 433 funds tracked by Wall St. Rank hold SNV as of Q3 2024.

  • Front Row Advisors reported no remaining Synovus position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 24 Synovus shares in Q3 2024, an estimated $974.
  • Front Row Advisors first reported a position in Synovus in Q1 2019 and held it in 21 quarters.
  • Front Row Advisors's Synovus position peaked at $1K in Q2 2023.
  • 433 funds tracked by Wall St. Rank held Synovus as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.